This is a single-centre, single-blind, non-comparative clinical trial to assess the safety of
the investigational product through clinical probability assessment.
Thirty-three female participants, aged between 18-45, will be required. Assessment of dermal
(dermatological) and gynecological acceptance, in addition to pH measurements and vaginal
force collection for microbiological analysis at the beginning and end of the study.